Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases.
Stock is 

SEC Filing Details

Document Details

Filing Date
Aug 24, 2018
Document Date
Aug 24, 2018
Form Description
CT ORDER
Filing Group
Other
Company
Agios Pharmaceuticals, Inc.
Issuer
AGIOS PHARMACEUTICALS INC